Jul 25 2017

Tenex at the Future of Healthcare Breakfast - Tallinn

Dan

Blog post image

This was a sold out event with 53 stakeholders present, among them: pharmaceutical industry representatives, US Embassy personnel, University of Tartu professors and doctors, representatives from Information Technology service providers.

The guest speakers were the Minister of Health (and leader of the Estonian Social Democratic Party, the junior party in the current government’s coalition), Jegveni Ossinivoski, as well as Tanel Ross, Chairman of the Haigekassa (Estonian Public Insurance Agency).

The Minister who was the first to speak. Here are the main points he raised:

  • Estonia spends around one billion Euros a year in public healthcare (around 760 Euros per capita) and he acknowledged, “we are small and poor” but always looking for ways to improve healthcare delivery (which he said is ‘solidarity-based’)

  • People are living longer and end-of-life treatment remains the single most expensive form of treatment (the last week of life is the most expensive of all)

  • He highlighted that the biggest challenges that remain a priority when it comes to the digital provision of healthcare: big data analysis and data protection (especially when it comes to sharing patient data across EU countries)

  • Digital healthcare is prevalent in Estonia, though there’s still room for improvement, with 90% of patients using e-prescription, 70% using online specialist referrals and 30% of adult patients access their medical data online.

The Chairman of the Haigekassa talked about the following:

  • A program aimed at mapping the genome of every Estonian (that would only cost 23 Million Euros, or about 17.50 Euros per capita)

  • The urgent need for data analysis of clinical data;

  • The challenge of the ever-narrowing clientele for specialized conditions (the less common the illness, the fewer people affected by it and the greater the cost to find appropriate treatment/cure for it);

  • The increasing challenge to deal with metastatic cancers (as an example, he mentioned 800 newly diagnosed cases of lung cases in the country each year and 600 of them already metastatic, as lung cancer is usually discovered at the late stages)

  • How to link technology with daily situations (as to get away from the huge expenses involved in personalized medicine).

All the points raised by the main guests were met with questions from the panelists which included representatives from the pharmaceutical and information technology industries.

After distilling the information from the panel and encounters at the event, we have identified several fields where Tenex has the opportunity to provide high quality solutions to healthcare partners:

  • Software design, coding services for biotech companies (free them from the burden of development tasks so they can focus strictly on research);

  • Cloud-based privacy protection solutions for all concerned government agencies and stakeholders to guarantee, among other things, patient confidentiality across borders;

  • Mobile applications for all end users (doctors, patients, pharmacists).

  • Big Data analytical models that would accelerate the pace of scientific research, and also augment the timeliness and accuracy of healthcare service delivery to end customers.